1067 related articles for article (PubMed ID: 16842217)
21. Mechanisms of drug resistance in chemotherapy for urogenital carcinoma.
Naito S; Yokomizo A; Koga H
Int J Urol; 1999 Sep; 6(9):427-39. PubMed ID: 10510888
[TBL] [Abstract][Full Text] [Related]
22. Zhankuic Acids A, B and C from
Teng YN; Wang YH; Wu TS; Hung HY; Hung CC
Biomolecules; 2019 Nov; 9(12):. PubMed ID: 31766413
[No Abstract] [Full Text] [Related]
23. Inhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer Treatment.
Waghray D; Zhang Q
J Med Chem; 2018 Jun; 61(12):5108-5121. PubMed ID: 29251920
[TBL] [Abstract][Full Text] [Related]
24. Not only P-glycoprotein: Amplification of the ABCB1-containing chromosome region 7q21 confers multidrug resistance upon cancer cells by coordinated overexpression of an assortment of resistance-related proteins.
Genovese I; Ilari A; Assaraf YG; Fazi F; Colotti G
Drug Resist Updat; 2017 May; 32():23-46. PubMed ID: 29145976
[TBL] [Abstract][Full Text] [Related]
25. Multidrug resistance: molecular mechanisms and clinical relevance.
Ling V
Cancer Chemother Pharmacol; 1997; 40 Suppl():S3-8. PubMed ID: 9272126
[TBL] [Abstract][Full Text] [Related]
26. Three decades of P-gp inhibitors: skimming through several generations and scaffolds.
Palmeira A; Sousa E; Vasconcelos MH; Pinto MM
Curr Med Chem; 2012; 19(13):1946-2025. PubMed ID: 22257057
[TBL] [Abstract][Full Text] [Related]
27. Reversal of multidrug resitance by natural substances from plants.
Molnár J; Engi H; Hohmann J; Molnár P; Deli J; Wesolowska O; Michalak K; Wang Q
Curr Top Med Chem; 2010; 10(17):1757-68. PubMed ID: 20645919
[TBL] [Abstract][Full Text] [Related]
28. Novel approaches to reversing anti-cancer drug resistance using gene-specific therapeutics.
Kobayashi H; Takemura Y; Miyachi H
Hum Cell; 2001 Sep; 14(3):172-84. PubMed ID: 11774737
[TBL] [Abstract][Full Text] [Related]
29. Development of Fourth Generation ABC Inhibitors from Natural Products: A Novel Approach to Overcome Cancer Multidrug Resistance.
Karthikeyan S; Hoti SL
Anticancer Agents Med Chem; 2015; 15(5):605-15. PubMed ID: 25584696
[TBL] [Abstract][Full Text] [Related]
30. Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition.
Zhou SF
Xenobiotica; 2008 Jul; 38(7-8):802-32. PubMed ID: 18668431
[TBL] [Abstract][Full Text] [Related]
31. Reversal of multidrug resistance by co-delivery of tariquidar (XR9576) and paclitaxel using long-circulating liposomes.
Patel NR; Rathi A; Mongayt D; Torchilin VP
Int J Pharm; 2011 Sep; 416(1):296-9. PubMed ID: 21703341
[TBL] [Abstract][Full Text] [Related]
32. Design, synthesis and biological evaluation of chalcones as reversers of P-glycoprotein-mediated multidrug resistance.
Yin H; Dong J; Cai Y; Shi X; Wang H; Liu G; Tang Y; Liu J; Ma L
Eur J Med Chem; 2019 Oct; 180():350-366. PubMed ID: 31325783
[TBL] [Abstract][Full Text] [Related]
33. Natural alkaloids as P-gp inhibitors for multidrug resistance reversal in cancer.
Joshi P; Vishwakarma RA; Bharate SB
Eur J Med Chem; 2017 Sep; 138():273-292. PubMed ID: 28675836
[TBL] [Abstract][Full Text] [Related]
34. Reversing agents for ATP-binding cassette (ABC) transporters: application in modulating multidrug resistance (MDR).
Lee CH
Curr Med Chem Anticancer Agents; 2004 Jan; 4(1):43-52. PubMed ID: 14754411
[TBL] [Abstract][Full Text] [Related]
35. Tenulin and isotenulin inhibit P-glycoprotein function and overcome multidrug resistance in cancer cells.
Chang YT; Wang CCN; Wang JY; Lee TE; Cheng YY; Morris-Natschke SL; Lee KH; Hung CC
Phytomedicine; 2019 Feb; 53():252-262. PubMed ID: 30668405
[TBL] [Abstract][Full Text] [Related]
36. Selective toxicity of NSC73306 in MDR1-positive cells as a new strategy to circumvent multidrug resistance in cancer.
Ludwig JA; Szakács G; Martin SE; Chu BF; Cardarelli C; Sauna ZE; Caplen NJ; Fales HM; Ambudkar SV; Weinstein JN; Gottesman MM
Cancer Res; 2006 May; 66(9):4808-15. PubMed ID: 16651436
[TBL] [Abstract][Full Text] [Related]
37. β-carotene reverses multidrug resistant cancer cells by selectively modulating human P-glycoprotein function.
Teng YN; Sheu MJ; Hsieh YW; Wang RY; Chiang YC; Hung CC
Phytomedicine; 2016 Mar; 23(3):316-23. PubMed ID: 26969385
[TBL] [Abstract][Full Text] [Related]
38. N,N-bis(cyclohexanol)amine aryl esters: the discovery of a new class of highly potent inhibitors of transporter-dependent multidrug resistance (MDR).
Teodori E; Dei S; Martelli C; Scapecchi S
Curr Top Med Chem; 2010; 10(17):1715-31. PubMed ID: 20645921
[TBL] [Abstract][Full Text] [Related]
39. Insight on Multidrug Resistance and Nanomedicine Approaches to Overcome MDR.
Mohammad IS; He W; Yin L
Crit Rev Ther Drug Carrier Syst; 2020; 37(5):473-509. PubMed ID: 33389848
[TBL] [Abstract][Full Text] [Related]
40. Targeting P-Glycoprotein: Nelfinavir Reverses Adriamycin Resistance in K562/ADR Cells.
Liu W; Meng Q; Sun Y; Wang C; Huo X; Liu Z; Sun P; Sun H; Ma X; Liu K
Cell Physiol Biochem; 2018; 51(4):1616-1631. PubMed ID: 30497065
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]